Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsRanbaxylaboratories

    Jump to

    • Sell Ranbaxy Labs; target of Rs 337: PINC Research

      PINC Research is bearish on Ranbaxy Labs and has recommended sell rating on the stock with a target of Rs 337 in its February 23, 2012 research report.

    • Sell Ranbaxy Laboratories; target Rs 355: PINC Research

      PINC Research is bearish on Ranbaxy Laboratories and has recommended sell rating on the stock with a target price of Rs 355 in its January 27, 2012 research report.

    • Sell Ranbaxy Labs; target of Rs 355: PINC Research

      PINC Research bearish on Ranbaxy Labs and has recommended sell rating on the stock with a target of Rs 355 in its January 27, 2012 research report.

    • Reduce Ranbaxy Laboratories; target Rs 355: PINC Research

      PINC Research is bearish on Ranbaxy Laboratories and has recommended reduce rating on the stock with a target price of Rs 355 in its December 21, 2011 research report.

    • Accumulate Ranbaxy Laboratories; target of Rs 513: Emkay

      Emkay Global Financial Services is bullish on Ranbaxy Laboratories and has recommended accumulate rating on the stock with a target price of Rs 513 in its December 7, 2011 research report.

    • Reduce Ranbaxy Labs; target of Rs 412: PINC Research

      PINC Research is bearish on Ranbaxy Labs and has recommended reduce rating on the stock with a target of Rs 412 in its December 1, 2011 research report.

    • Short Ranbaxy Laboratories; target Rs 355: ICICIdirect.com

      ICICIdirect.com is bearish on Ranbaxy Laboratories and has recommended short rating on the stock with a target price of Rs 355 in its November 24, 2011 research report.

    • Buy Ranbaxy Laboratories; target Rs 577: Angel Broking

      Angel Broking has recommended buy rating on Ranbaxy Laboratories with a revised target price of Rs 577 in its November 16, 2011 report.

    • Buy Ranbaxy; target of Rs 501: IIFL

      IIFL is bullish on Ranbaxy Laboratories and has recommended buy rating on the stock with a target of Rs 501 in its September 16, 2011 research report.

    • Reduce Ranbaxy Labs; target of Rs 424: Emkay

      Emkay Global Financial Services is bearish on Ranbaxy Labs and has recommended reduce rating on the stock with a target of Rs 424 in its August 6, 2011 research report.

    • Hold Ranbaxy Labs; target of Rs 483: PINC Research

      PINC Research has recommended hold rating on Ranbaxy Labs with a target of Rs 483, in its August 5, 2011 research report.

    • Hold Ranbaxy Labs; target of Rs 483: PINC Research

      PINC Research has recommended hold rating on Ranbaxy Labs with a target of Rs 483, in its August 5, 2011 research report.

    • Buy Ranbaxy Labs; target of Rs 560: IIFL

      IIFL is bullish on Ranbaxy Laboratories and has recommended buy rating on the stock with a target of Rs 560 in its June 30, 2011 research report.

    • Buy Ranbaxy Labs; target of Rs 670: KRChoksey

      KRChoksey is bullish on Ranbaxy Labs and has recommended buy rating on the stock with a target of Rs 670 in its May 24, 2011 research report.

    • Buy Ranbaxy Labs; target of Rs 593: Angel Broking

      Angel Broking is bullish on Ranbaxy Labs and has recommended buy rating on the stock with a target of Rs 593 in its May 11, 2011 research report.

    • Hold Ranbaxy Labs; target of Rs 412: Emkay

      Emkay Global Financial Services has maintained hold rating on Ranbaxy Laboratories with a target price of Rs 412 in its May 11, 2011 research report.

    • Hold Ranbaxy Labs; target of Rs 480: PINC Research

      PINC Research has recommended hold rating on Ranbaxy Labs with a target of Rs 480, in its May 11, 2011 research report.

    • Buy Ranbaxy Labs; target of Rs 670: KRChoksey

      KRChoksey is bullish on Ranbaxy Labs and has recommended buy rating on the stock with a target of Rs 670 in its May 11, 2011 research report.

    • Hold Ranbaxy Labs; target of Rs 480: PINC Research

      PINC Research has recommended hold rating on Ranbaxy Labs with a target of Rs 480, in its March 22, 2011 research report.

    • Hold Ranbaxy Labs; target of Rs 396: Emkay

      Emkay Global Financial Services has recommended hold rating on Ranbaxy Labs with a target of Rs 396, in its February 24, 2011 research report.

    • Buy Ranbaxy Labs; target of Rs 630: Anand Rathi Securities

      Anand Rathi Securities is bullish on Ranbaxy Labs and has recommended buy rating on the stock with a target of Rs 630 in its February 23, 2011 research report.

    • Ranbaxy Labs a market performer; target of Rs 538: Karvy

      Karvy Stock Broking is bullish on Ranbaxy Laboratories and has recommended a market performer rating on the stock with a target of Rs 538 in its February 23, 2011 research report.

    • Buy Ranbaxy Laboratories; target of Rs 588: Angel Broking

      Angel Broking is bullish on Ranbaxy Laboratories and has recommended buy rating on the stock with a target of Rs 588 in its February 22, 2011 research report.

    • Buy Ranbaxy Labs; target of Rs 670: KRChoksey

      KRChoksey is bullish on Ranbaxy Labs and has recommended buy rating on the stock with a target of Rs 670 in its February 22, 2011 research report.

    • Hold Ranbaxy Laboratories; target of Rs 480: PINC Research

      PINC Research has recommended hold rating on Ranbaxy Laboratories with a target of Rs 480, in its February 23, 2011 research report.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347